Rao KVU, Shorgar N. Development of a stability-indicating UPLC method for quantification of mirvetuximab soravtansine-gynx in pharmaceutical formulations using quality by design (QbD) principles. J. Appl. Pharm. Res. [Internet]. 2025Apr.30 [cited 2026Feb.16];13(2):204-13. Available from: https://japtronline.com/index.php/joapr/article/view/977